The Effect of Sperm DNA Fragmentation Index on the Outcome of Intrauterine Insemination and Intracytoplasmic Sperm Injection

CONTEXT

Elevated sperm DNA fragmentation index (DFI) is found to affect normal embryonic development, implantation and fetal development after intrauterine insemination (IUI), in vitro fertilization and intracytoplasmic sperm injection (ICSI). Estimation of DFI by terminal deoxynucleotidyl transferase-mediated fluorescent deoxy uridine nucleotide nick end labeling (TUNEL) assay was found to have a high predictive value for pregnancy after fertility treatments.

AIM

This study aims to find the effect of increased sperm DNA fragmentation by TUNEL assay on reproductive outcome after IUI and ICSI.

PRIMARY OBJECTIVE

To find the association of DFI and pregnancy rate in IUI and ICSI.

SECONDARY OBJECTIVES

To find the association of DFI with fertilization and implantation in ICSI. To find the association of DFI with miscarriage rate.

SETTINGS AND DESIGN

A prospective observational study performed at a tertiary care university teaching hospital.

SUBJECTS AND METHODS

105 male partners of infertile couple planned for IUI and ICSI underwent estimation of sperm-DFI by TUNEL assay. The treatment outcomes were compared between the DFI-positive (≥20%) and DFI-negative (<20%) groups.

STATISTICAL ANALYSIS USED

Statistical analysis was performed by SPSS version 17, Software. P < 0.05 was considered statistically significant.

RESULTS

The men with abnormal semen analysis were significantly higher in the DFI-positive group (77.15% vs. 22.85%). There was no significant difference in the pregnancy rate in IUI cycles (17.6% vs. 11.8%); but in the ICSI, the pregnancy rate was significantly reduced in the DFI-positive group (16.7% vs. 47.4%).

CONCLUSIONS

Elevated DFI significantly affects the pregnancy rate in ICSI cycles.

Correlation of serum estradiol level on the day of ovulation trigger with the reproductive outcome of intracytoplasmic sperm injection

BACKGROUND:

Serum estradiol (E₂) levels are measured in in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI), to assess the ovarian response and to predict ovarian hyperstimulation syndrome. The impact of peak E₂ levels on IVF-ICSI outcome was found to be inconsistent in the previous studies.

AIM:

To evaluate the impact of the serum E₂ levels on the day of ovulation trigger with the reproductive outcome of ICSI.

SETTINGS AND DESIGN:

Retrospective observational study. ART Center, at a Tertiary Care University Teaching Hospital.

SUBJECTS AND METHODS:

Eighty-nine infertile women, who underwent ICSI with fresh embryo transfer over a period of 3 years, were included in the study. The study subjects were grouped based on the serum E₂ level on the day of ovulation trigger:- Group I - <1000 pg/ml, Group II - 1000–2000 pg/ml, Group III – 2000.1-3000 pg/ml, Group IV – 3000.1–4000 pg/ml, and Group V >4000 pg/ml. The baseline characteristics and controlled ovarian hyperstimulation (COH) outcome were compared among the study groups.

STATISTICAL ANALYSIS USED:

Chi-square test, Student's t-test, ANOVA, and logistic regression analysis.

RESULTS:

The study groups were comparable with regard to age, body mass index, ovarian reserve. Group V had significantly higher number of oocytes retrieved than I and II (18.90 vs. 11.36 and 11.33; P = 0.009). Group IV showed significantly higher fertilization rate than I, III, and V; (92.23 vs. 77.43, 75.52, 75.73; P = 0.028). There were no significant differences in the implantation rates (P = 0.368) and pregnancy rates (P = 0.368).

CONCLUSION:

Higher E₂ levels on the day of ovulation trigger would predict increased oocyte yield after COH. E₂ levels in the range of 3000–4000 pg/ml would probably predict increased fertilization and pregnancies in ICSI cycles.